Literature DB >> 15827045

Outcome following onset of juvenile idiopathic inflammatory arthritis: I. frequency of different outcomes.

N Adib1, A Silman, W Thomson.   

Abstract

OBJECTIVE: To determine the outcome, following the onset of juvenile idiopathic inflammatory arthritis, in terms of remission of disease activity, loss of function and structural damage based on a review of the available published data.
METHODS: Electronic databases were searched for major studies publishing outcome data in the past 10 yr in juvenile idiopathic arthritis, juvenile rheumatoid arthritis and juvenile chronic arthritis, and 21 studies were selected. The proportions of children in the different categories of the outcomes of interest are described. Data were stratified where possible by disease subtype.
RESULTS: There were major differences between the studies reviewed in terms of study design, case selection and the results obtained. In general, children with systemic- or polyarticular-onset disease were much less likely to go into remission than those with oligoarticular onset, although the remission rates in the latter group ranged from 36 to 84%. Several different approaches were used to assess functional outcome but the pattern of results between the different subgroups was the same as with remission. Similarly, children with polyarticular disease in all the cohorts reviewed were substantially more likely to have erosive radiological damage on follow-up. The rates of individual outcomes, even within a subgroup, varied considerably between studies and this does not appear to be explained solely by differences in methodology.
CONCLUSIONS: There remains a considerable lack of clarity in the prognosis following onset of juvenile idiopathic arthritis for the major outcomes considered, although those with oligoarthritis at presentation have the best outcome. The ability to offer accurate prognosis is particularly important to both reassure parents and guide treatment at disease onset. To achieve this, large definitive prospective studies will be required.

Entities:  

Mesh:

Year:  2005        PMID: 15827045     DOI: 10.1093/rheumatology/keh620

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.

Authors:  M L Stoll; Q-Z Li; J Zhou; M Punaro; N J Olsen
Journal:  Clin Exp Rheumatol       Date:  2011-09-01       Impact factor: 4.473

2.  Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states.

Authors:  Claudia Macaubas; Khoa Nguyen; Chetan Deshpande; Carolyn Phillips; Ariana Peck; Tzielan Lee; Jane L Park; Christy Sandborg; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2009-10-29       Impact factor: 3.969

3.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

Review 4.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

5.  Evaluation of children with juvenile idiopathic arthritis in southeastern Turkey: a single center experience.

Authors:  V Şen; A Ece; Ü Uluca; A Güneş; S Yel; I Tan; D Karabel; B Yıldırım; K Haspolat
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

6.  High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.

Authors:  Mikel Alberdi-Saugstrup; Marek Zak; Susan Nielsen; Troels Herlin; Ellen Nordal; Lillemor Berntson; Anders Fasth; Marite Rygg
Journal:  Rheumatol Int       Date:  2017-03-10       Impact factor: 2.631

7.  Protocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA.

Authors:  Gordon J Hendry; Deborah E Turner; John McColl; Paula K Lorgelly; Roger D Sturrock; Gordon F Watt; Michael Browne; Janet Gardner-Medwin; Lorraine Friel; Jim Woodburn
Journal:  J Foot Ankle Res       Date:  2009-06-30       Impact factor: 2.303

8.  Discordant inflammatory changes in the apophyseal and sacroiliac joints: serial observations in enthesitis-related arthritis.

Authors:  Timothy J P Bray; Thomas Amies; Kanimozhi Vendhan; Paul Humphries; Debajit Sen; Yiannis Ioannou; Margaret A Hall-Craggs
Journal:  Br J Radiol       Date:  2016-07-04       Impact factor: 3.039

9.  Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.

Authors:  Alessandro Consolaro; Nicolino Ruperto; Giovanni Filocamo; Stefano Lanni; Giulia Bracciolini; Marco Garrone; Silvia Scala; Luca Villa; Giuseppe Silvestri; Daniela Tani; Alessandra Zolesi; Alberto Martini; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-20       Impact factor: 3.054

Review 10.  An overview of genetics of paediatric rheumatic diseases.

Authors:  Patricia Woo; Robert A Colbert
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.